 Borderline Personality Disorder: New Reasons for Hope is one in a series being published by Johns Hopkins University Press on major psychiatric disorders. 

Borderline Personality Disorder: New Reasons for Hope

 In a recent interview on 60 Minutes, Harvard psychologist Irving Kirsch, PhD, commented, “the difference between the effect of a placebo and the effect of an antidepressant is minimal for most people.”

On the Efficacy of Psychiatric Drugs

 Much could be gained if an agreed minimum set of appropriate and important outcomes was measured and reported in all clinical trials in a particular area. 

Reviewers Question Utility of Clinical Trials in Schizophrenia

 David Cronenberg’s film "A Dangerous Method" tells the story of the relationship between Freud and Jung and a woman named Sabina who had a considerable influence on both of them.

A Dangerous Method

 with enough juice to jump-start a heart . . . back to the Bo Diddley beat . . . We don’t amp ourselves up to sing the body electric . . .

Guitar Shopping

Insight can be assessed in the course of a typical evaluation or follow-up interview with augmentation by questions borrowed from any of the validated insight rating scales.

Determination and Documentation of Insight in Psychiatric Inpatients

We know that different people, cultures, and traditions all grieve differently. Yet it is ultimately our capacity for resilience that allows each of us to process the grief-inducing event in his or her own way.

Sinking Into Grief

 The emergence of accountable care organizations (ACOs) may spur changes in psychiatric care, especially among office-based practitioners. 

Opportunities and Challenges Lurk for Psychiatrists as ACOs Proliferate

 When thinking about recent advances in psychopharmacology, we often point to new molecules with similar mechanisms of action but with better safety and tolerability profiles, or to molecules with novel mechanisms that effect positive change greater than that with existing treatments.

Introduction: Strategies for Treatment

Adequate treatment of the underlying psychiatric illness consistently appears to be the most effective use of medication in suicidal patients.

Psychopharmacological Treatment to Reduce Suicide Risk

Several studies have been undertaken to test the efficacy of drugs in the management of aggression and hostility in patients with schizophrenia and other mood disorders.

Psychopharmacology of Aggression and Violence in Mental Illness

 This discussion focuses on approaches to improve medication adherence, particularly in reference to helping adolescents remain on recommended psychopharmacological regimens when transitioning from acute to long-term maintenance.

Psychiatric Times Vol 29 No 4